Naseruddin Hoti
Naseruddin Hoti
Johns Hopkins School of Medicine
Verified email at jhmi.edu
Title
Cited by
Cited by
Year
Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain
S Feng, Y Yang, Y Mei, L Ma, D Zhu, N Hoti, M Castanares, M Wu
Cellular signalling 19 (10), 2056-2067, 2007
3652007
Downregulation of homologous recombination DNA repair genes by HDAC inhibition in prostate cancer is mediated through the E2F1 transcription factor
SK Kachhap, N Rosmus, SJ Collis, MSQ Kortenhorst, MD Wissing, ...
PloS one 5 (6), e11208, 2010
1372010
Chronic administration of valproic acid inhibits prostate cancer cell growth in vitro and in vivo
Q Xia, J Sung, W Chowdhury, C Chen, N Höti, S Shabbeer, M Carducci, ...
Cancer Research 66 (14), 7237-7244, 2006
1362006
Comprehensive analysis of protein glycosylation by solid-phase extraction of N-linked glycans and glycosite-containing peptides.
ZH Sun S, Shah P, Eshghi ST, Yang W, Trikannad N, Yang S, Chen L, Aiyetan P ...
Nat Biotechnol, 2015
126*2015
Prevalence of HBV and HBV vaccination coverage in health care workers of tertiary hospitals of Peshawar, Pakistan
S Attaullah, S Khan, S Ayaz, SN Khan, I Ali, N Hoti, S Siraj
Virology journal 8 (1), 1-5, 2011
782011
Integrated proteomic and glycoproteomic analyses of prostate cancer cells reveal glycoprotein alteration in protein abundance and glycosylation
P Shah, X Wang, W Yang, ST Eshghi, S Sun, N Hoti, L Chen, S Yang, ...
Molecular & Cellular Proteomics 14 (10), 2753-2763, 2015
752015
A single amino acid change (Asp 53→ Ala53) converts Survivin from anti-apoptotic to pro-apoptotic
Z Song, S Liu, H He, N Hoti, Y Wang, S Feng, M Wu
Molecular biology of the cell 15 (3), 1287-1296, 2004
602004
Valproic acid, a histone deacetylase inhibitor, is an antagonist for oncolytic adenoviral gene therapy
N Höti, W Chowdhury, JT Hsieh, MD Sachs, SE Lupold, R Rodriguez
Molecular Therapy 14 (6), 768-778, 2006
552006
Triphenyl Tin Benzimidazolethiol, a Novel Antitumor Agent, Induces Mitochondrial-Mediated Apoptosis in Human Cervical Cancer Cells via Suppression of HPV-18 …
N Höti, J Ma, S Tabassum, Y Wang, M Wu
Journal of biochemistry 134 (4), 521-528, 2003
512003
Valproic Acid Inhibits the Growth of Cervical Cancer both In Vitro and In Vivo
S Sami, N Höti, HM Xu, Z Shen, X Huang
Journal of biochemistry 144 (3), 357-362, 2008
492008
p53-dependent apoptotic mechanism of a new designer bimetallic compound tri-phenyl tin benzimidazolethiol copper chloride (TPT-CuCl2): in vivo studies in Wistar rats as well as …
N Höti, D Zhu, Z Song, Z Wu, S Tabassum, M Wu
Journal of Pharmacology and Experimental Therapeutics 311 (1), 22-33, 2004
382004
The antiangiogenic and therapeutic implications of endostatin
B Ren, N Hoti, X Rabasseda, YZ Wang, M Wu
Methods Find Exp Clin Pharmacol 25 (3), 215-224, 2003
352003
Site-specific fucosylation analysis identifying glycoproteins associated with aggressive prostate cancer cell lines using tandem affinity enrichments of intact glycopeptides …
J Zhou, W Yang, Y Hu, N Höti, Y Liu, P Shah, S Sun, D Clark, S Thomas, ...
Analytical chemistry 89 (14), 7623-7630, 2017
292017
Detection of aggressive prostate cancer associated glycoproteins in urine using glycoproteomics and mass spectrometry
X Jia, J Chen, S Sun, W Yang, S Yang, P Shah, N Hoti, B Veltri, H Zhang
Proteomics 16 (23), 2989-2996, 2016
232016
Androgen receptor attenuation of Ad5 replication: implications for the development of conditionally replication competent adenoviruses
N Höti, Y Li, CL Chen, WH Chowdhury, DC Johns, Q Xia, A Kabul, ...
Molecular Therapy 15 (8), 1495-1503, 2007
232007
Simultaneous analyses of N-linked and O-linked glycans of ovarian cancer cells using solid-phase chemoenzymatic method
S Yang, N Höti, W Yang, Y Liu, L Chen, S Li, H Zhang
Clinical proteomics 14 (1), 1-11, 2017
212017
Suppression of tumor growth using a recombinant adenoviral vector carrying the dominant-negative mutant gene Survivin-D53A in a nude mice model
DE Zhu, N Höti, Z Song, L Jin, Z Wu, Q Wu, M Wu
Cancer Gene Therapy 13 (8), 762-770, 2006
162006
Armoring CRAds with p21/Waf-1 shRNAs: the next generation of oncolytic adenoviruses
N Höti, WH Chowdhury, S Mustafa, J Ribas, M Castanares, T Johnson, ...
Cancer gene therapy 17 (8), 585-597, 2010
152010
Overexpression of α (1, 6) fucosyltransferase in the development of castration-resistant prostate cancer cells
N Höti, S Yang, Y Hu, P Shah, MC Haffner, H Zhang
Prostate cancer and prostatic diseases 21 (1), 137-146, 2018
102018
Genetic determinants of β-thalassemia intermedia in Pakistan
J Khan, N Ahmad, S Siraj, N Hoti
Hemoglobin 39 (2), 95-101, 2015
82015
The system can't perform the operation now. Try again later.
Articles 1–20